Ancient drug could save NHS millions each year when treating older patients with heart conditions

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

Chasing CAR-T, biotech finds its next gold rush in autoimmune disease

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But there’s one field that has

October 14, 2024

AbbVie drops two early-stage ADCs, including Pfizer-partnered oncology program

AbbVie removed two early-stage antibody-drug conjugates from its pipeline, per a Wednesday update to its pipeline webpage. The Chicago-area Big Pharma culled ABBV-011 and the

August 25, 2023

New noninvasive device promises early stroke risk detection

A team of researchers from the Keck School of Medicine of USC and California Institute of Technology (Caltech) have developed a potential new way to

September 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.